Engineered microorganisms for increasing product yield in biotransformations, related methods and systems
There are disclosed recombinant microorganisms engineered to increase product yield in a biotransformation. In an embodiment, the microorganisms are engineered to increase the amount of NAD(P)H available for a NAD(P)H-requiring oxidoreductase involved in a biotransformation. There are also disclosed methods and systems for using recombinant microorganisms engineered to increase the amount of NAD(P)H available for a NAD(P)H-requiring oxidoreductase involved in a biotransformation. Other embodiments are also disclosed.
1 . A recombinant microorganisms engineered to increase the amount of NAD(P)H available for a biotransformation NAD(P)H-requiring oxidoreductase, the biotransformation NAD(P)H-requiring oxidoreductase involved in a biotransformation of a substrate to a product in the recombinant microorganism, wherein the recombinant microorganism is engineered to inactivate a respiratory pathway in the microorganism.
2 . The recombinant microorganism of claim 1 , further engineered to express the biotransformation NAD(P)H-requiring oxidoreductase.
3 . The recombinant microorganism of claim 1 , wherein inactivation of a respiratory pathway is performed by inactivating a respiratory NAD(P)H-requiring oxidoreductase, the respiratory NAD(P)H-requiring oxidoreductase involved in the respiratory pathway to be inactivated.
4 . The recombinant microorganism of claim 3 , wherein the respiratory NAD(P)H-requiring oxidoreductase is a dehydrogenase, an oxidase, oxidoreductase and/or reductase.
5 . The recombinant microorganism of claim 4 , wherein the native NAD(P)H-requiring oxidoreductase is selected from the group consisting of NDH-1 dehydrogenase, NDH-2 dehydrogenase, a quinol oxidase complex, a quinol oxidase complex, a quinol:cytochrome c oxidoreductase, a cytochrome oxidase, and a terminal reductase.
6 . The recombinant microorganism of claim 5 , wherein the native NAD(P)H-requiring oxidoreductase is selected from the group consisting of NADH dehydrogenase, NADH oxidase, NADPH oxidase, ubiquinol-cytochrome c reductase, quinol oxidase complex, Cytochrome c oxidase, Nitrate reductase, Periplasmic nitrate reductase, Nitrite reductase, Nitric oxide reductase, Nitrous oxide reductase, ATP sulfurylase, Adenylylsulfate reductase, dissimilatory sulfite reductase, dissimilatory sulfite reductase, Dimethyl sulfoxide reductase, Trimethylamine N-oxide reductase, Trimethylamine N-oxide reductase, Trimethylamine N-oxide reductase, Nitrite reductase complex, Respiratory arsenate reductase, Iron-cytochrome-c reductase.
7 . The recombinant microorganism of claim 1 , wherein inactivation of a respiratory pathway is performed by inactivating a redox active small molecule, involved in the respiratory pathway to be inactivated.
8 . The recombinant microorganism of claim 7 , wherein the redox active small molecule is a quinone,
9 . The recombinant microorganism of claim 8 , wherein the redox active small molecule is a ubiquinone or menaquinone
10 . The recombinant microorganism of claim 1 , wherein the recombinant microorganism is engineered to further inactivate one or more fermentation pathways in the microorganism
11 . The recombinant microorganism of claim 10 , wherein the one or more fermentation pathways are inactivated by inactivating one or more enzymes selected from the group consisting of Fumarate Reductase, Lactate Dehydrogenase, Pyruvate oxidase, Phosphate transacetylase, Acetate kinase, Aldehyde/Alcohol dehydrogenase, Pyruvate-Formate lyase, 1,3-propanediol dehydrogenase, Glycerol dehydratase, α-acetolactate synthase, Acetoin reductase, 2,3,-butanediol dehydrogenase, α-acetolactate decarboxylase or acetoin reductase, propionyl-CoA:succinate CoA transferase, methylmalonyl-CoA carboxyltransferase, Acetate CoA-transferase phosphotransbutyrylase, Butyrate kinase, Butanol dehydrogenase, Butyraldehyde dehydrogenase, Butyryl-CoA dehydrogenase, Crotonase, Hydroxybutyryl-CoA dehydrogenase, Thiolase, Acetoacetate decarboxylase, Formate hydrogen lyase complex, Pyruvate decarboxylase, alcohol dehydrogenase, Glycerol-3-phosphate phosphohydrolase, Formate hydrogen lyase complex, Hydrogenase, Formate dehydrogenase, D-lactate dehydrogenase, Pyruvate formate lyase, Acetaldehyde/alcohol dehydrogenase, Phosphate acetyl transferase/acetate kinase A, Fumarate reductase, and Pyruvate oxidase.
12 . The recombinant microorganism of claim 1 , wherein the substrate is a carbon source, the product is a alcohol and the biotransformation NAD(P)H-requiring oxidoreductase is an enzyme that catalyzes direct conversion of the carbon source into the alcohol.
13 . The recombinant microorganism of claim 12 , wherein the biotransformation NAD(P)H-requiring oxidoreductase is an oxidase or a reductase.
14 . The recombinant microorganism of claim 12 , wherein the biotransformation NAD(P)H-requiring oxidoreductase is an oxidase or a reductase selected from the group consisting of alcohol dehydrogenase, lactate dehydrogenase, leucine dehydrogenase, nicotinic acid hydroxylase, naphthalene dioxygenase, benzoate dioxygenase, cyclopentanone monooxygenase, cyclohexanone monooxygenase, steroid monooxygenases.
15 . The recombinant microorganism of claim 12 , wherein the biotransformation NAD(P)H-requiring oxidoreductase is a P450 cytochrome, a methane monooxygenases, a dioxygenase, styrene monooxygenases, a Baeyer-Villiger monooxygenases or a ketoreductase.
16 . The recombinant microorganism of claim 15 , wherein the substrate is an alkane and the product is an alcohol
17 . The recombinant microorganism of claim 16 , wherein the recombinant microorganism is E. coli.
18 . The recombinant microorganism of claim 1 , wherein the biotransformation is performed by an NAD(P)H requiring pathway.
19 . The recombinant microorganism of claim 18 , wherein the NAD(P)H requiring pathway is for the production of butanol
20 . The recombinant microorganism of claim 16 , wherein said microorganism is selected from the group consisting of: GEVO711, GEVO713, GEVO715, GEVO717, GEVO734, GEVO736, GEVO738, GEVO740, GEVO741, GEVO746, GEVO747, GEVO748, GEVO749, GEVO750, GEVO751, GEVO752, GEVO756, GEVO757, GEVO759, GEVO761, GEVO763, GEVO765, GEVO784, GEVO785, GEVO786, GEVO787, GEVO788, GEVO789, GEVO1317, GEVO1318, GEVO1319, GEVO1320, GEVO1321, GEVO1322, GEVO1323, GEVO1324, GEVO1325, GEVO1326, GEVO1327, GEVO1328, GEVO1329, GEVO1330, GEVO800, GEVO803, GEVO1331, GEVO831, GEVO1332, GEVO1333, GEVO802, GEVO805, GEVO1334, GEVO1335, GEVO1336, GEVO1337, GEVO818, GEVO822, GEVO1338, GEVO1339, GEVO1340, GEVO1341, GEVO817, GEVO821, GEVO1342, GEVO1343, GEVO1344, GEVO1345, GEVO801, GEVO804, GEVO1346, GEVO1347, GEVO1348 and GEVO1349
21 . A recombinant microorganisms engineered to increase the amount of NAD(P)H available for a biotransformation NAD(P)H-requiring oxidoreductase, biotransformation NAD(P)H-requiring oxidoreductase involved in a biotransformation of a substrate to a product in the recombinant microorganism, wherein the recombinant microorganism is engineered to activate TCA cycle pathway in the microorganism.
22 . The recombinant microorganism of claim 21 , further engineered to express the biotransformation NAD(P)H-requiring oxidoreductase.
23 . The recombinant microorganism of claim 21 , wherein the TCA cycle has been enabled by activating one or more of enzymes selected from the group consisting of alpha-ketoglutarate dehydrogenase, an NADH dependant fumarate reductase, and a dimeric citrate synthase including at least one of the mutations selected from the group consisting of Y145A, R163L, K167A, and D362N.
24 . The recombinant microorganism of claim 23 , wherein the recombinant microorganism is further engineered to inactivate at least one of the native enzymes selected from the group consisting of fumarate reductase/succinate dehydrogenase, citrate synthase and alpha-ketoglutarate dehydrogenase.
25 . A method for performing a biotransformation of a substrate, the method comprising performing the biotransformation in a recombinant microorganism according to claim 2 .
26 . A method for performing a biotransformation of a substrate, the method comprising performing the biotransformation in a recombinant microorganism according to claim 22 .
27 . The method of claim 25 , wherein the biotransformation is the conversion of a carbon source into an alcohol.
28 . The method of claim 26 , wherein the biotransformation is the conversion of a carbon source into an alcohol.
29 . A system for performing a biotransformation of a substrate, the system comprising at least one of the recombinant microorganisms of claim 1 and the substrate of the biotransformation.
30 . The system of claim 27 , further comprising a heterologous NAD(P)H-requiring oxidoreductase involved in the biotransformation of the substrate.